Also trades as: SLXN (NASDAQ) · $vol 1M
SLXNW NASDAQ
Silexion Therapeutics Ltd.
1W: -39.4%
1M: -47.4%
3M: -81.8%
YTD: -84.6%
1Y: -80.1%
$0.01
-0.00 (-21.05%)
Weekly Expected Move ±45.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
11 relationships11
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2024-08-21
Earliest Filing
2025-01-15
Latest Filing
investor: 5
partner: 3
acquirer: 2
target: 1
Counterparties (Filed by SLXNW)
11 relationshipsCompanies named in SLXNW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Silexion Therapeutics Corp | SLXNW | acquirer | Company entering into an amendment to an ordinary share purchase agreement | 2025-01-15 | View |
| White Lion Capital, LLC | — | investor | Investor party to the ordinary share purchase agreement amendment | 2025-01-15 | View |
| Moringa Acquisition Corp | — | acquirer | SPAC that merged with registrant in business combination | 2024-08-21 | View |
| August M.S. Ltd. | — | partner | Wholly-owned subsidiary of registrant used in merger | 2024-08-21 | View |
| Moringa Acquisition Merger Sub Corp | — | partner | Wholly-owned subsidiary of registrant used in merger | 2024-08-21 | View |
| Silexion Therapeutics Ltd. | SLXNW | target | Israeli company merged into registrant | 2024-08-21 | View |
| EarlyBird Capital, Inc. | — | investor | Representative of underwriters for Moringa's IPO and holder of convertible note | 2024-08-21 | View |
| Greenstar, LP | — | investor | PIPE investor purchasing shares in private placement | 2024-08-21 | View |
| White Lion Capital, LLC | — | investor | Counterparty to equity line of credit agreement | 2024-08-21 | View |
| Guangzhou Sino-Israel Bio-Industry Investment Fund I | — | investor | Security holder of Silexion receiving shares for transfer of Chinese subsidiary interest | 2024-08-21 | View |
| Continental Stock Transfer & Trust Company | — | partner | Counterparty to warrant assignment and assumption agreement | 2024-08-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-30 | Regulation FD; Exhibits | View | |
| 2026-09-29 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-09-28 | Regulation FD; Exhibits | View | |
| 2026-09-25 | Delisting Notice | View | |
| 2026-09-25 | Shareholder Vote | View | |
| 2026-08-21 | Delisting Notice | View | |
| 2026-08-14 | Earnings Release; Exhibits | View | |
| 2026-08-13 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-08-13 | Other Events; Exhibits | View | |
| 2026-08-10 | Regulation FD; Exhibits | View | |
| 2026-08-04 | Regulation FD; Exhibits | View | |
| 2026-08-03 | Other Events | View | |
| 2026-07-31 | Officer/Director Change | View | |
| 2026-07-29 | Regulation FD; Exhibits | View | |
| 2026-07-21 | Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-05-29 | Bylaws Amendment; Other Events; Exhibits | View | |
| 2026-05-26 | Other Events; Exhibits | View | |
| 2026-05-18 | Earnings Release; Exhibits | View | |
| 2026-05-15 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-05-13 | Regulation FD; Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR